M3, Inc. (MTHRY)
OTCMKTS · Delayed Price · Currency is USD
7.54
+0.07 (0.94%)
Oct 15, 2025, 11:43 AM EDT
M3, Inc. Market Cap
M3, Inc. has a market cap or net worth of $10.09 billion as of October 15, 2025. Its market cap has increased by 56.14% in one year.
Market Cap
10.09B
Enterprise Value
9.76B
Revenue
2.13B
Ranking
n/a
PE Ratio
35.27
Stock Price
$7.54
Market Cap Chart
Since September 16, 2004, M3, Inc.'s market cap has increased from 488.38M to 10.09B, an increase of 1,965.54%. That is a compound annual growth rate of 15.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 10.09B | 67.14% |
| Dec 30, 2024 | 6.04B | -46.29% |
| Dec 29, 2023 | 11.24B | -38.99% |
| Dec 30, 2022 | 18.42B | -46.06% |
| Dec 30, 2021 | 34.15B | -46.65% |
| Dec 30, 2020 | 64.01B | 210.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |